Sort   by:  
 Page size 
Mass spectrometry based on Data Independent Acquisition (DIA) strategies has developed into powerful tools suitable for precision medicine applications. Assays performed in this setting provide confident protein identification and precise quantification on an absolute scale when combined with stable...
ORGANISM(S): Homo Sapiens 
2024-07-03 | PXD037946 | panorama
Next-generation quantitative proteomics based on data-independent acquisition mass spectrometry (DIA-MS) enables large-scale sample profiling, a necessity for (pre)clinical studies with heterogeneous samples. To date, most cancer protein profiling studies have focussed on a single cancer type. Here ...
ORGANISM(S): Homo sapiens (Human) 
2025-05-30 | PXD054790 | Pride
Proteome profiling of formalin-fixed paraffin-embedded (FFPE) specimens has gained traction in recent years for the analysis of human clinical material, notably cancer tissue for the discovery of molecular biomarkers. However, published reports so far focused on certain cancer entities and comprised...
ORGANISM(S): Homo Sapiens (ncbitaxon:9606) 
2024-06-14 | MSV000095036 | MassIVE
This pan-cancer cell line proteomic atlas comprises proteomic data acquired by data independent acquisition (specifically, SWATH) mass spectrometry for 949 cancer cell lines. Cell lines were processed in technical triplicate, with duplicates acquired on different mass spectrometers, alongside HEK293...
ORGANISM(S): Homo sapiens (Human) 
2022-07-13 | PXD030304 | Pride
Understanding dysregulated genes and pathways in cancer is critical for precision oncology. Integrating mass spectrometry-based proteomic data with transcriptomic data presents unique opportunities for systematic analyses of dysregulated genes and pathways in pan-cancer. Here, we compiled a comprehe...
ORGANISM(S): Homo Sapiens 
2024-12-24 | PXD059207 |
Proteome analysis of Biotin- PLANE pull-down assays
ORGANISM(S): Homo Sapiens 
2020-11-26 | PXD022747 |
Sort   by:  
 Page size